The outbreak of coronavirus disease 2019 (COVID-19) has adversely affected the public domain causing unprecedented cases and high mortality across the globe. This has brought back the concept of biosafety into the spotlight to solve biosafety problems in developing diagnostics and therapeutics to treat COVID-19. The advances in nanotechnology and material science in combination with medicinal chemistry have provided a new perspective to overcome this crisis. The authors of this article discuss the efforts of researchers in the field of material science in developing personal protective equipment (PPE), detection devices, vaccines, drug delivery systems, and medical equipment. Such a synergistic approach of disciplines can strengthen the research to develop biosafety products in solving biosafety problems.
Highlights
- Insight into the concept of biosafety materials for combating COVID-19 is presented.
- The advances in nanotechnology to develop diagnostics and therapeutics are highlighted.
- The increasing demand for PPE makes it necessary to design protocols for their reusability.
- Significance of medicinal chemistry and material science in the vaccine and drug development to mitigate COVID-19 is discussed.
- Future scope in further developing biosafety materials to combat the future pandemic outbreaks are highlighted.
Keywords: COVID-19, SARS-CoV-2, Biosafety, Nanomaterials, Diagnostics, Therapeutics
